combination of novel agents in cll: is this the final answer?
Published 4 years ago • 2.9K plays • Length 24:17Download video MP4
Download video MP3
Similar videos
-
27:18
novel treatment options in cll
-
22:47
the sequencing of novel agents: does it matter?
-
13:55
debate: optimal approach for the management of cll patients with del(17p) - novel agents
-
21:19
cll: sequencing monotherapy vs. combination therapy
-
20:21
novel agents in elderly cll patients: should the approach be different?
-
16:24
chemotherapy vs novel agents in young cll patients: is there still a role for chemo?
-
18:49
use of novel prognostic markers in practice for cll
-
16:28
the latest in chronic lymphocytic leukemia (cll) treatments! | the patient story
-
13:49
roger talks about living with cll
-
8:56
my leukaemia symptoms | patient | doctor | leukaemia | cancer
-
1:18:46
"starving cancer - beyond the metro map" with jane mclelland
-
12:34
debate: is it appropriate to treat patients with cll earlier in the era of novel agents? - no
-
20:40
cll: treatment for btki progressors
-
29:14
ibrutinib resistance-mechanisms and options in cll
-
14:07
novel agents in the pipeline for cll & lymphoma
-
15:02
debate: will novel-agent based combination therapy become standard of care for cll? - no
-
25:38
cll: chemotherapy and ibrutinib based regimens
-
19:42
treatment options for the young cll patient with deletion 17p: do they need a different approach?
-
23:32
what's next in cll?
-
1:32
novel agent combinations: the future of cll
-
22:08
role of chemotherapy in cll management
-
14:21
debate: which is the optimal approach for cll? - fcr